UPB CagriSema 5MG/5MG

Cagrilintide / Semaglutide Blend

Current Batch: 11048-004
Test Date: Feb 9th, 2026
Purity: 99.771
Cagrilintide Net Content: 6.73
Semaglutide New Content: 6.03mg
Cag/Sema(GLP -CS)
Cap Color: Pink

Product Description
This blended formulation combines cagrilintide and Semaglutide, synthetic peptide analogs frequently referenced in metabolic and receptor pathway research. Manufacturing is performed through controlled production workflows, with internal quality systems supporting lot level confirmation of identity and purity for each component.

Supplied in sealed laboratory vials, the material is intended for analytical investigation, assay development, and experimental applications in professional research environments where reproducibility and documentation are essential.

Handling & Storage
Maintain under recognized laboratory conditions appropriate for peptide materials. Record batch information within institutional tracking systems and apply established contamination control procedures.

Proudly crafted and produced in the USA!!! Be sure to look for our new labels with the MADE IN USA SHIELD.

All research peptides arrive in a dry lyophilized powder. All research supplies including bacteriostatic water are sold separately. These are not FDA approved medications. These are non-compounded research-use chemicals intended for research use only. Not for human or veterinary use